Haemonetics Corporation
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2022 | 5.8% | 3.3% | 2.3% |
| FY2023 | 14.1% | 7.3% | 6.0% |
| FY2024 | 12.2% | 6.7% | 5.4% |
| FY2025 | 20.4% | 9.6% | 6.8% |
| FY2026 | 12.2% | 4.8% | 4.1% |
Returns on Capital
| Fiscal Year | ROE | ROI | ROA |
|---|---|---|---|
| FY2022 | 5.8% | 3.3% | 2.3% |
| FY2023 | 14.1% | 7.3% | 6.0% |
| FY2024 | 12.2% | 6.7% | 5.4% |
| FY2025 | 20.4% | 9.6% | 6.8% |
| FY2026 | 12.2% | 4.8% | 4.1% |